Literature DB >> 29756343

Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.

Stanley Teleka1, Christel Häggström2,3,4, Gabriele Nagel5,6, Tone Bjørge7,8, Jonas Manjer9, Hanno Ulmer10, Fredrik Liedberg11, Sara Ghaderi7, Alois Lang6, Håkan Jonsson12, Staffan Jahnson13, Marju Orho-Melander1, Steinar Tretli8, Pär Stattin3, Tanja Stocks1.   

Abstract

Previous studies on metabolic factors and bladder cancer (BC) risk have shown inconsistent results and have commonly not investigated associations separately by sex, smoking, and tumor invasiveness. Among 811,633 participants in six European cohorts, we investigated sex-specific associations between body mass index (BMI), mid-blood pressure (BP, [systolic + diastolic]/2), plasma glucose, triglycerides, total cholesterol and risk of BC overall, non-muscle invasive BC (NMIBC) and muscle invasive BC (MIBC). Among men, we additionally assessed additive interactions between metabolic factors and smoking on BC risk. During follow-up, 2,983 men and 754 women were diagnosed with BC. Among men, triglycerides and BP were positively associated with BC risk overall (hazard ratio [HR] per standard deviation [SD]: 1.17 [95% confidence interval (CI) 1.06-1.27] and 1.09 [1.02-1.17], respectively), and among women, BMI was inversely associated with risk (HR: 0.90 [0.82-0.99]). The associations for BMI and BP differed between men and women (pinteraction ≤ 0.005). Among men, BMI, cholesterol and triglycerides were positively associated with risk for NMIBC (HRs: 1.09 [95% CI 1.01-1.18], 1.14 [1.02-1.25], and 1.30 [1.12-1.48] respectively), and BP was positively associated with MIBC (HR: 1.23 [1.02-1.49]). Among women, glucose was positively associated with MIBC (HR: 1.99 [1.04-3.81]). Apart from cholesterol, HRs for metabolic factors did not significantly differ between MIBC and NMIBC, and there were no interactions between smoking and metabolic factors on BC. Our study supports an involvement of metabolic aberrations in BC risk. Whilst some associations were significant only in certain sub-groups, there were generally no significant differences in associations by smoking or tumor invasiveness.
© 2018 UICC.

Entities:  

Keywords:  bladder cancer; metabolic factors; muscle-invasive bladder cancer; non-muscle invasive bladder cancer; smoking

Mesh:

Substances:

Year:  2018        PMID: 29756343     DOI: 10.1002/ijc.31597

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis.

Authors:  Morgan Connaughton; Mahsa Dabagh
Journal:  Healthcare (Basel)       Date:  2022-06-09

2.  Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.

Authors:  Helga H Hektoen; Trude E Robsahm; Bettina K Andreassen; Jo S Stenehjem; Karol Axcrona; Alison Mondul; Randi E Gislefoss
Journal:  Cancer Med       Date:  2020-04-21       Impact factor: 4.452

3.  Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis.

Authors:  Stanley Teleka; George Hindy; Isabel Drake; Alaitz Poveda; Olle Melander; Fredrik Liedberg; Marju Orho-Melander; Tanja Stocks
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

4.  Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts.

Authors:  Stanley Teleka; Sylvia H J Jochems; Christel Häggström; Angela M Wood; Bengt Järvholm; Marju Orho-Melander; Fredrik Liedberg; Tanja Stocks
Journal:  Cancer Med       Date:  2021-01-16       Impact factor: 4.452

5.  An overview of patients with urothelial bladder cancer over the past two decades: a Surveillance, Epidemiology, and End Results (SEER) study.

Authors:  Yan Zang; Xiao Li; Yifei Cheng; Feng Qi; Ningli Yang
Journal:  Ann Transl Med       Date:  2020-12

6.  Can Routine Blood and Urine Parameters Reveal Clues to Detect Bladder Cancer? A Case-Control Study.

Authors:  Dan-Qi Wang; Juan Shuai; Hang Zheng; Zhong-Qiang Guo; Qiao Huang; Xiao-Feng Xu; Xiao-Dong Li; Hao Zi; Dao-Jing Ming; Xuan-Yi Ren; Xian-Tao Zeng
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

7.  CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-κB activity.

Authors:  Yue Xia; Minghuan Ge; Ling Xia; Guang Shan; Huijun Qian
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.